Skip to content
← Index board

Health Optimization Index

Apigenin

Nick’s assessment
Promising
Research evidence
D, early evidence
Attention
22.0 / 100▲ Rising this week
5.8/ 10

BioHarmony score

Apigenin is a chamomile-derived flavonoid with a credible GABA-A calming mechanism and modest human anxiety evidence from chamomile extract trials, especially Mao 2016 and Amsterdam 2009. Pure isolated apigenin still lacks adequate human RCTs for sleep, anxiety, testosterone, or NAD+. The popular 50 mg sleep dose is mixed in practice: some people get real calm, many feel nothing, and chronic 100+ mg use has a reversible mood-blunting signal.

Read the full report Benefits, risks and practical guidance.

Read Nick’s assessment Why it earned this rating

Apigenin is a 5.5–6.0/10 fit for people who want a gentle calming option, not a heavy sleep drug or a longevity shortcut. The best human signal still comes from chamomile extract trials, where apigenin is one active flavonoid among many: Amsterdam 2009 found a modest generalized-anxiety benefit, and Mao 2016 supports longer-term symptom reduction without a clean relapse-prevention win. Sleep evidence is weaker, with Adib-Hajbaghery 2017 pointing to chamomile extract in older adults rather than isolated apigenin capsules. The practical read is simple: Apigenin belongs after the basics, works best for anxious or sleep-fragile responders, and deserves extra caution with sedatives, anticoagulants, pregnancy, allergies, or chronic high-dose use.

✅ Best for: Anxious-baseline adults who want a gentle GABAergic calming option and are not using sedatives or anticoagulants. Chamomile responders who want to compare tea, standardized extract, and isolated apigenin. People building a sleep stack who are willing to test magnesium and theanine first, then add 25-50 mg apigenin only if needed. GAD-profile users closer to the chamomile trial populations in Mao 2016 and Amsterdam 2009. Careful self-experimenters interested in CD38/NAD+ who understand Escande 2013 is not human validation.

❌ Avoid if: You are a healthy low-anxiety user expecting a sleep transformation from 50 mg. You prioritize daytime emotional vitality and have a history of anhedonia, low motivation, or poor response to GABAergic compounds. You have Asteraceae or ragweed-family allergy. You take warfarin, narrow-therapeutic-index anticoagulants, benzodiazepines, Z-drugs, gabapentin, alcohol-heavy evening protocols, or other sedatives without clinician review. You are pregnant, lactating, preparing for surgery, or managing estrogen-sensitive disease. You are taking apigenin mainly for testosterone, aromatase inhibition, cancer prevention, or NAD+ longevity claims that remain preclinical or in vitro.

Share your experience

Your answers are optional and help other readers — they never change my score. How community input works.

Tried it in real life?

How would you assess it?

Favorable is the strongest rating, followed by Promising, then Experimental. Overhyped means the claims outrun the evidence or interest is fading.

Make a 12-month prediction Will it rise or fall in the Index?

Choose a direction and your confidence. Correct predictions earn leaderboard points.

Your 12-month call on Apigenin
How sure are you?

Your prediction is final once submitted. We’ll check it in 12 months. See the leaderboard →

Updated Sep 21, 2026 How the Index ranks →

Educational information, not medical advice. Ask a qualified clinician about risks and interactions. Independent ratings: no affiliate links, sponsored placements or paid rankings.